Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 9 | 2018 | 60 | 2.040 |
Why?
|
| Electric Stimulation Therapy | 5 | 2017 | 41 | 1.280 |
Why?
|
| Anticonvulsants | 5 | 2006 | 56 | 0.800 |
Why?
|
| Epilepsy, Temporal Lobe | 3 | 2017 | 22 | 0.540 |
Why?
|
| Electroencephalography | 4 | 2017 | 77 | 0.530 |
Why?
|
| Epilepsies, Partial | 4 | 2017 | 13 | 0.490 |
Why?
|
| Implantable Neurostimulators | 2 | 2014 | 5 | 0.460 |
Why?
|
| Valproic Acid | 2 | 2004 | 13 | 0.440 |
Why?
|
| Pharmaceutical Services | 1 | 2013 | 2 | 0.420 |
Why?
|
| Pharmacists | 1 | 2013 | 16 | 0.420 |
Why?
|
| Dyslipidemias | 1 | 2013 | 16 | 0.410 |
Why?
|
| Hypolipidemic Agents | 1 | 2013 | 26 | 0.410 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 28 | 0.340 |
Why?
|
| Brain Mapping | 3 | 2017 | 147 | 0.290 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2017 | 10 | 0.280 |
Why?
|
| Deep Brain Stimulation | 2 | 2017 | 36 | 0.270 |
Why?
|
| Developmental Disabilities | 1 | 2006 | 25 | 0.260 |
Why?
|
| Humans | 19 | 2023 | 27074 | 0.230 |
Why?
|
| Reality Testing | 1 | 2004 | 2 | 0.230 |
Why?
|
| Magnetoencephalography | 1 | 2004 | 2 | 0.220 |
Why?
|
| Landau-Kleffner Syndrome | 1 | 2003 | 1 | 0.220 |
Why?
|
| Perception | 1 | 2004 | 77 | 0.220 |
Why?
|
| Functional Laterality | 1 | 2004 | 59 | 0.220 |
Why?
|
| Attitude to Health | 1 | 2004 | 99 | 0.210 |
Why?
|
| Vascular System Injuries | 1 | 2023 | 3 | 0.210 |
Why?
|
| Angiography | 1 | 2023 | 28 | 0.210 |
Why?
|
| Patient Compliance | 1 | 2004 | 150 | 0.210 |
Why?
|
| Brain | 2 | 2017 | 1649 | 0.190 |
Why?
|
| Sleep | 1 | 2003 | 328 | 0.170 |
Why?
|
| Intellectual Disability | 2 | 2013 | 43 | 0.170 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 1792 | 0.160 |
Why?
|
| Child, Preschool | 4 | 2008 | 641 | 0.160 |
Why?
|
| Adolescent | 6 | 2017 | 2172 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2023 | 3485 | 0.150 |
Why?
|
| Feasibility Studies | 3 | 2017 | 220 | 0.150 |
Why?
|
| Child | 4 | 2008 | 1295 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 44 | 0.150 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 155 | 0.140 |
Why?
|
| Neocortex | 1 | 2017 | 31 | 0.140 |
Why?
|
| Female | 9 | 2018 | 15213 | 0.130 |
Why?
|
| Male | 10 | 2018 | 14772 | 0.130 |
Why?
|
| Middle Aged | 7 | 2018 | 8923 | 0.120 |
Why?
|
| Young Adult | 4 | 2017 | 1994 | 0.120 |
Why?
|
| Delayed-Action Preparations | 2 | 2004 | 28 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2018 | 1890 | 0.110 |
Why?
|
| Time Factors | 3 | 2014 | 1433 | 0.110 |
Why?
|
| Spasms, Infantile | 1 | 2013 | 1 | 0.110 |
Why?
|
| Hospitals, Veterans | 1 | 2013 | 6 | 0.110 |
Why?
|
| Professional Role | 1 | 2013 | 31 | 0.100 |
Why?
|
| Lipids | 1 | 2013 | 51 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2023 | 3538 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2013 | 260 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 329 | 0.100 |
Why?
|
| Primary Health Care | 1 | 2013 | 83 | 0.100 |
Why?
|
| Mutation | 1 | 2013 | 348 | 0.090 |
Why?
|
| Veterans | 1 | 2013 | 96 | 0.090 |
Why?
|
| Aged | 4 | 2018 | 8997 | 0.090 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2010 | 61 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 474 | 0.080 |
Why?
|
| Adult | 6 | 2017 | 7831 | 0.080 |
Why?
|
| Electrodiagnosis | 1 | 2008 | 5 | 0.070 |
Why?
|
| Epidural Space | 1 | 2008 | 19 | 0.070 |
Why?
|
| Monitoring, Physiologic | 1 | 2008 | 68 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2008 | 117 | 0.070 |
Why?
|
| Electrodes, Implanted | 2 | 2017 | 21 | 0.070 |
Why?
|
| Isoxazoles | 1 | 2005 | 6 | 0.060 |
Why?
|
| Ureteral Calculi | 1 | 2005 | 6 | 0.060 |
Why?
|
| Kidney Calculi | 1 | 2005 | 7 | 0.060 |
Why?
|
| Self Administration | 1 | 2004 | 18 | 0.060 |
Why?
|
| Incidence | 1 | 2006 | 759 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2004 | 12 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2004 | 132 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2004 | 63 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2004 | 83 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 216 | 0.050 |
Why?
|
| Extremities | 1 | 2023 | 27 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2023 | 23 | 0.050 |
Why?
|
| Drug Hypersensitivity | 1 | 2003 | 6 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2023 | 38 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2003 | 30 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2004 | 420 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 348 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 333 | 0.050 |
Why?
|
| Prognosis | 1 | 2003 | 785 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 1112 | 0.040 |
Why?
|
| Seizures | 1 | 2018 | 67 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2018 | 126 | 0.040 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2017 | 1 | 0.030 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2017 | 2 | 0.030 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2017 | 4 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 2017 | 15 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2017 | 59 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 766 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 4777 | 0.030 |
Why?
|
| Lennox Gastaut Syndrome | 1 | 2013 | 1 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2013 | 4 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2013 | 3 | 0.030 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2013 | 2 | 0.030 |
Why?
|
| Exome | 1 | 2013 | 7 | 0.030 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 16 | 0.030 |
Why?
|
| Probability | 1 | 2013 | 88 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 406 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2013 | 115 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 564 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 381 | 0.020 |
Why?
|
| Quality of Life | 1 | 2014 | 629 | 0.020 |
Why?
|
| Electrodes | 1 | 2008 | 13 | 0.020 |
Why?
|
| Craniotomy | 1 | 2008 | 22 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2008 | 63 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 122 | 0.020 |
Why?
|
| Calcium Citrate | 1 | 2005 | 1 | 0.020 |
Why?
|
| Carbamazepine | 1 | 2005 | 6 | 0.010 |
Why?
|
| Piracetam | 1 | 2005 | 8 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 2005 | 25 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 161 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 310 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2005 | 227 | 0.010 |
Why?
|